Enriched MSCs were seeded onto culture plates at a density of 0.1 × 106 cells/cm2 in α-MEM containing 100 units/ml penicillin (Gibco) and 100 μg/ml streptomycin (Gibco). The media were changed after 72 h and adherent cells were maintained in culture with twice weekly media changes.
To induce osteogenic differentiation, BMSCs were treated with 100 nM dexamethasone, 10 mM β-glycerophosphate disodium and 50 μg/ml ascorbic acid.
BMSCs were treated in vitro with tubastatin A (Sigma) in DMSO at 8 μM for 21 days. Vehicle controls were treated with culture medium with DMSO only.